Barry Griffiths
Barry Griffiths is the CEO of New Zealand Sleep, focusing on testing and solutions for sleep apnoea. He acknowledges the availability of melatonin as a positive development but warns that its use could exacerbate breathing issues for individuals with sleep apnoea, leading to disrupted sleep patterns despite potential benefits in duration.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
New Zealand:
Barry Griffiths stated that making melatonin available was a positive step.
7